Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: CODX

Co-Diagnostics, Inc.

Healthcare | Medical - Devices
$1.15
Volume79.4K

Co-Diagnostics, Inc. (NASDAQ: CODX) is a medical - devices company trading at $1.15. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:49 UTC.

What Co-Diagnostics, Inc. does

Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect nucleic acid molecules like DNA and RNA, with a focus on infectious disease detection. The company uses proprietary technology called Co-Primers, a novel approach to polymerase chain reaction test design that reduces false positives and simplifies complex testing procedures.

Summarized from Co-Diagnostics, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Quote
Price$1.15
Volume79.4K shares
Valuation
Return on equity-227.33%

Revenue, margins & earnings

FY2021 Net income: $37MFY2021 Taxes & interest: $9MFY2021 Operating expenses: $40MFY2021 Cost of revenue: $12M$98MFY2021FY2022: net loss $14M on revenue $34M$34MFY2022FY2023: net loss $35M on revenue $7M$7MFY2023FY2024: net loss $38M on revenue $4M$4MFY2024FY2025: net loss $47M on revenue $622,489$622,489FY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-05-27
Most recent filed transactions — May 2026:
  • 2026-05-27Chief Financial OfficerOption exercise-3,750—
  • 2026-05-27Chief Executive OfficerAward4,584—
  • 2026-05-27DirectorOption exercise-1,695—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Co-Diagnostics, Inc. do?

Co-Diagnostics, Inc. is a medical - devices company, listed on NASDAQ as CODX.

What is CODX's valuation?

CODX trades at $1.15, as of 2026-10-11.

When did CODX last file with the SEC?

Co-Diagnostics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-09-25. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:49 UTC. This page is also available as JSON at /api/data?ticker=CODX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for CODX and 5,000+ tickers.

Create a free account — keep CODX
For your agent
GET /api/data?ticker=CODX

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt